Protagenic Therapeutics, Inc. (PTIX) Financials
PTIX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 2.1 million | 6.8 million |
| Sept. 30, 2025 | 2.1 million | 9.7 million |
| June 30, 2025 | 6.5 million | 10.5 million |
| March 31, 2025 | 988650 | 1.1 million |
PTIX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -410427 | 206829 |
| Sept. 30, 2025 | -1.5 million | -5019 |
| June 30, 2025 | -1.2 million | 125127 |
| March 31, 2025 | -1.1 million | 236014 |
PTIX Net Income
No data available :(
PTIX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 2.2 million | - | - |
| Sept. 30, 2025 | 2.7 million | - | - |
| June 30, 2025 | 4.1 million | - | - |
| March 31, 2025 | 872960 | - | - |
PTIX Shares Outstanding
PTIX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 6 | 153786 | 154817 | - |
| Sept. 30, 2025 | 3 | 273229 | 159915 | - |
| June 30, 2025 | 3 | 394112 | 814262 | - |
| March 31, 2025 | 3 | 880372 | 567736 | - |
PTIX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | 12572 |
| June 30, 2025 | - | 12571 |
| March 31, 2025 | - | 12572 |
PTIX
Price: $0.41
52 week price:
Earnings Per Share: -13.13 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6800
Market Capitalization: 905104